Accel Wealth Management Amgen Inc Transaction History

Accel Wealth Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	SELL	$225.79 - $275.2 $2,032 - $2,476	-9 Reduced 2.44%	360 $87,000
Q3 2022 Oct 12, 2022	SELL	$224.46 - $253.15 $46,463 - $52,402	-207 Reduced 35.94%	369 $86,000
Q2 2022 Aug 03, 2022	BUY	$230.71 - $256.74 $461 - $513	2 Added 0.35%	576 $143,000
Q1 2022 Apr 29, 2022	BUY	$219.27 - $242.57 $438 - $485	2 Added 0.35%	574 $140,000
Q4 2021 Jan 18, 2022	BUY	$198.88 - $227.6 $44,748 - $51,210	225 Added 64.84%	572 $129,000
Q3 2021 Nov 04, 2021	SELL	$212.27 - $248.7 $4,457 - $5,222	-21 Reduced 5.71%	347 $74,000
Q2 2021 Aug 03, 2021	BUY	$233.58 - $259.14 $233 - $259	1 Added 0.27%	368 $90,000
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $4,660 - $5,430	-21 Reduced 5.41%	367 $91,000
Q4 2020 Jan 27, 2021	BUY	$216.38 - $257.67 $83,955 - $99,975	388 New	388 $89,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Accel Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Accel Wealth Management with notifications on news.